Earendil Labs

About Earendil Labs

Earendil Labs is focused on transforming drug discovery by developing AI platforms for protein therapeutics research and development, and applying these to discover and develop novel drugs.

Products & Services

AI Platforms for Protein Therapeutics:AI-driven platforms designed to enhance research and development in protein therapeutics.

Novel Drugs:Discovery and development of new drugs using AI technology.

Specialties

AI in Drug Discovery Protein Therapeutics

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: financing rounds T: - FT: financing rounds	A: 787000000 MR: - FA: $787 million FAN: 787000000	D: 2026-03-20 FD: 2026-03-20	7 investors

financing rounds Latest

2026-03-20

$787.0M

7 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Earendil Labs Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised